SCHEMBL29592452

SCHEMBL29592452

O=c1[nH]c(=O)c2cc(I)c(Br)c(F)c2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
TYMP P19971 2/20 0.32
DPYD Q12882 1/20 0.32
PNP P00491 1/20 0.32
GDA Q9Y2T3 1/20 0.31
KDM4E B2RXH2 2/20 0.31
CA12 O43570 1/20 0.31
PARP1 P09874 1/20 0.31
CA9 Q16790 1/20 0.31
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
GRIN2B Q13224 1/20 0.30
GRIN2C Q14957 1/20 0.30
GRIN3A Q8TCU5 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21379214 1.00 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL25814975 0.83 IDH1 (0.39) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL24616050 0.80 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL29388927 0.80 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL16637455 0.80 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL24004705 0.78 GRIN2D (0.38) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL25820506 0.76 DPYD (0.38) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL25330088 0.75 SIRT2 (0.41) TYMPKDM4ECA12PARP1CA9
SCHEMBL23668650 0.74 F2 (0.34)
SCHEMBL25412579 0.74 KDM4E (0.37) KDM4EGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4596551-A1 COMPOUNDS WITH ANTI-KRAS MUTANT TUMOR ACTIVITY Trasveda Ltd. (KY) 2025-08-06 EP disclosed
CN-118084870-A Condensed ring compound 豪夫迈·罗氏有限公司 2024-05-28 CN disclosed
CN-118084867-A Condensed ring compound 豪夫迈·罗氏有限公司 2024-05-28 CN disclosed
CN-118084866-A Condensed ring compound 豪夫迈·罗氏有限公司 2024-05-28 CN disclosed
CN-118084868-A Condensed ring compound 豪夫迈·罗氏有限公司 2024-05-28 CN disclosed
CN-117800975-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-04-02 CN disclosed
CN-112105419-B Condensed ring compound 豪夫迈·罗氏有限公司 2024-03-29 CN disclosed
CN-110267957-B Quinazoline compounds 安斯泰来制药株式会社 2022-04-26 CN disclosed